Van Hulzen Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$112K	Sell	19,382 -1,000	-5%	-$6.63K	0.01%	358
2025 Q4	$160K	Sell	20,382 -1,800	-8%	-$14.2K	0.01%	331
2025 Q3	$181K	Buy	22,182 +5,058	+30%	+$33.6K	0.01%	326
2025 Q2	$80K	Buy	17,124 +848	+5%	+$3.88K	0.01%	320
2025 Q1	$89.4K	Sell	16,276 -1,750	-10%	-$7.06K	0.01%	305
2024 Q4	$61.1K	Hold	18,026	–	–	﹤0.01%	471
2024 Q3	$51K	Hold	18,026	–	–	﹤0.01%	318
2024 Q2	$41K	Hold	18,026	–	–	﹤0.01%	301
2024 Q1	$40K	Hold	18,026	–	–	﹤0.01%	320
2023 Q4	$42K	Hold	18,026	–	–	﹤0.01%	309
2023 Q3	$34K	Hold	18,026	–	–	﹤0.01%	298
2023 Q2	$47K	Sell	18,026 -2,252	-11%	-$5.73K	﹤0.01%	300
2023 Q1	$33K	Buy	+20,278	New	+$25.4K	﹤0.01%	299